WeLeader Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,229	3,243	-	-	-
Enterprise Value	3,792	3,845	-	-	-
Last Close Price	71.00	73.70	-	-	-
PE Ratio	16.40	19.05	-	-	-
PS Ratio	3.04	3.27	-	-	-
PB Ratio	2.82	3.57	-	-	-
P/TBV Ratio	2.82	3.59	-	-	-
P/FCF Ratio	70.05	30.01	-	-	-
P/OCF Ratio	12.93	11.63	-	-	-
EV/Sales Ratio	3.57	3.88	-	-	-
EV/EBITDA Ratio	10.59	15.83	-	-	-
EV/EBIT Ratio	15.98	17.96	-	-	-
EV/FCF Ratio	82.27	35.59	-	-	-
Debt / Equity Ratio	0.75	0.88	0.74	1.09	0.79
Debt / EBITDA Ratio	2.41	2.47	2.07	2.30	1.14
Debt / FCF Ratio	18.70	7.37	5.34	-	1.30
Asset Turnover	0.50	0.53	0.56	0.83	-
Inventory Turnover	6.51	8.00	9.71	12.54	-
Quick Ratio	1.32	1.04	0.94	0.89	1.13
Current Ratio	1.59	1.26	1.12	1.04	1.29
Return on Equity (ROE)	18.86%	19.41%	20.41%	30.64%	-
Return on Assets (ROA)	6.91%	7.18%	7.43%	9.80%	-
Return on Invested Capital (ROIC)	11.43%	11.84%	11.97%	17.70%	20.43%
Return on Capital Employed (ROCE)	12.90%	14.00%	14.90%	16.80%	25.50%
Earnings Yield	5.92%	5.25%	-	-	-
FCF Yield	1.43%	3.33%	-	-	-
Dividend Yield	4.74%	4.57%	-	-	-
Payout Ratio	80.19%	56.18%	19.54%	6.35%	21.14%
Buyback Yield / Dilution	-5.47%	-1.55%	-35.00%	-8.28%	-
Total Shareholder Return	-0.72%	3.02%	-35.00%	-8.28%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.